1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomarkers Prev 2016;25:16-27.
3. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 2017;26:444-57.
4. Weigelt B, Peterse JL, van ‘t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005;5:591-602.
5. Nielsen HM, Overgaard M, Grau C, Jensen AR, et al; Danish Breast Cancer Cooperative Group. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006;24:2268-75.
6. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116-26.
7. Hasan T, Ortel B, Solban N, Pogue BW. Photodynamic therapy of cancer. 7th edition. Hamilton, Ontario: BC Decker, Inc.; 2006. pp. 537-48.
8. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010;110:2795-838.
9. Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Letters 2012;326:8-16.
10. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-8.
11. Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S, et al. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 1996;14:59-66.
12. Ahmad N, Mukhtar H. Mechanism of photodynamic therapy-induced cell death. Methods Enzymol 2000;319:342-58.
13. Ortel B, Shea CR, Calzavara-Pinton P. Molecular mechanisms of photodynamic therapy. Front Biosci (Landmark Ed) 2009;14:4157-72.
14. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56:125-43.
15. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol 2003;120:325-31.
16. Campbell SM, Tyrrell J, Marshall R, Curnow A. Effect of MAL-photodynamic therapy on hypertrophic scarring. Photodiagnosis Photodyn Ther 2010;7:183-8.
17. Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol 2004;11:322-7.
18. Allison RR, Sibata C, Mang TS, Bagnato VS, Downie GH, et al. Photodynamic therapy for chest wall recurrence from breast cancer. Photodiagnosis Photodyn Ther 2004;1:157-71.
19. Liu Y, Hou G, Zhang X, Liu JJ, Zhang S, et al. A pilot randomized clinical study of the additive treatment effect of photodynamic therapy in breast cancer patients with chest wall recurrence. J Breast Cancer 2014;17:161-6.
20. Maytin EV, Anand S, Riha M, Lohser S, Tellez A, et al. 5-Fluorouracil enhances protoporphyrin IX accumulation and lesion clearance during photodynamic therapy of actinic keratoses: a mechanism-based clinical trial. Clin Cancer Res 2018;24:3026-35.
21. Sinha AK, Anand S, Ortel BJ, Chang Y, Mai Z, et al. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 2006;95:485-95.
22. Anand S, Honari G, Hasan T, Elson P, Maytin EV. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res 2009;15:3333-43.
23. Anand S, Wilson C, Hasan T, Maytin EV. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Cancer Res 2011;71:6040-50.
24. Anand S, Rollakanti KR, Brankov N, Brash DE, Hasan T, et al. Fluorouracil enhances photodynamic therapy of squamous cell carcinoma via a p53-independent mechanism that increases protoporphyrin IX levels and tumor cell death. Mol Cancer Ther 2017;16:1092-101.
25. Rollakanti KR, Anand S, Maytin EV. Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer. Cancer Med 2015;4:633-42.
26. Anand S, Hasan T, Maytin EV. Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors. Mol Cancer Ther 2013;12:1638-50.
27. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998;34:1274-81.
28. Yasuno H, Kurasawa M, Yanagisawa M, Sato Y, Harada N, et al. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes. Oncol Rep 2013;29:451-8.
29. Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005;27:23-44.
30. Venturini M. Rational development of capecitabine. Eur J Cancer 2002;38:3-9.
31. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008;8:228.
32. Duan X, Chan C, Guo N, Han W, Weichselbaum RR, et al. Photodynamic therapy mediated by nontoxic core-shell nanoparticles synergizes with immune checkpoint blockade to elicit antitumor immunity and antimetastatic effect on breast cancer. J Am Chem Soc 2016;138:16686-95.
33. Kolinsky K, Zhang YE, Dugan U, Heimbrook D, Packman K, et al. Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts. Anticancer Res 2009;29:91-8.
34. Toi M, Masuda N, Lee SJ. Capecitabine for primary breast cancer. Oncotarget 2017;8:110739-40.
35. Toi M, Masuda N, Ohashi Y. Adjuvant capecitabine for breast cancer. N Engl J Med 2017;377:791-2.
36. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-61.
37. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016;7:27-31.
38. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8.
39. Anand S, Rollakanti KR, Horst RL, Hasan T, Maytin EV. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma. Photochem Photobiol 2014;90:1126-35.
40. Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001; doi: 10.1002/0471142735.im2002s39.
41. Paschall AV, Liu K. An orthotopic mouse model of spontaneous breast cancer metastasis. J Vis Exp 2016; doi: 10.3791/54040.
42. Longo JP, Muehlmann LA, Miranda-Vilela AL, Portilho FA, de Souza LR, et al. Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model. J Biomed Nanotechnol 2016;12:689-99.
43. Kim JB, Urban K, Cochran E, Lee S, Ang A, et al. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 2010;5:e9364.
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.